✨ Free AI Report
4D Molecular Therapeutics, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview 4D Molecular Therapeutics, Inc.
Research Preview

4D Molecular Therapeutics, Inc.: Business Overview, Financials & Competitive Analysis

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company leverages a proprietary platform called Therapeutic Vector Evol...

Analyst-debate audio for 4D Molecular Therapeutics, Inc.

AskCyborg analysts argue the bull and bear cases for 4D Molecular Therapeutics, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
4D Molecular Therapeutics, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Late-stage gene therapy company with promising lead ophthalmology program advancing toward commercial potential, supported by...

Read the full analyst-debate transcript →
Industry Biotechnology - Gene Therapy
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest 4D Molecular Therapeutics, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

4D Molecular Therapeutics, Inc. Overview

Pro stress-test →

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company leverages a proprietary platform called Therapeutic Vector Evolution that combines directed evolution with synthetic AAV capsid sequences to create targeted genetic medicines.

Strategic Profile

Pro stress-test →

Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V.

Competitive Landscape

Pro stress-test →

4D Molecular Therapeutics competes in the gene therapy sector against other AAV-based platforms and modalities. Key competitive areas include ophthalmology (competing with companies like Astellas and established biopharmaceutical players) and specialty rare diseases. The company's differentiation lies in its Therapeutic Vector Evolution platform enabling tailored AAV vector development.

Industry Context

4D Molecular Therapeutics, Inc. operates in Biotechnology - Gene Therapy.

Key facts

Founded: 2013 · Headquarters: Emeryville, California · Employees: 227 · Revenue: $120K · Market cap: $505M

What the analysts stress-tested

The top findings that survived the multi-agent debate for 4D Molecular Therapeutics, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when 4D Molecular Therapeutics, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Adeno-associated virus (AAV) gene therapiesStrategic partner in ophthalmology and gene therapy development→CRISPR and gene editing therapiesAlternative genetic medicine approaches→Traditional anti-VEGF therapiesStandard of care for wet AMD and DME→

Compare 4D Molecular Therapeutics, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

4D Molecular Therapeutics, Inc. operates in Biotechnology - Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Gene Therapy research →
NEW · MCP server

Ask your AI assistant about 4D Molecular Therapeutics, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare 4D Molecular Therapeutics, Inc. and its top competitor on Cyborg Score”
“What did 4D Molecular Therapeutics, Inc. do this quarter?”
“Is 4D Molecular Therapeutics, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does 4D Molecular Therapeutics, Inc. do?+
4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions. The company leverages a proprietary platform called Therapeutic Vector Evol...
What is 4D Molecular Therapeutics, Inc.'s Cyborg Score?+
4D Molecular Therapeutics, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are 4D Molecular Therapeutics, Inc.'s main competitors?+
Named competitors include Adeno-associated virus (AAV) gene therapies, CRISPR and gene editing therapies, Traditional anti-VEGF therapies. The full competitive landscape is in the AskCyborg report.
How can I get the full 4D Molecular Therapeutics, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the 4D Molecular Therapeutics, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track 4D Molecular Therapeutics, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology - Gene Therapy research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Neurogene Inc.7MeiraGTx Holdings plc7REGENXBIO Inc.6Takara Bio Inc.6Voyager Therapeutics, Inc.5Rocket Pharmaceuticals, Inc.